Lupin gets tentative FDA nod for Revefenacin inhalation solution
The drug is indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD)
The drug is indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD)
Sheshadri brings with him extensive leadership experience spanning healthcare, diagnostics, telecom, and consumer goods industries
The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients
Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges
The country’s strength lies not just in technology availability but in adoption behaviour
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Access to genomic testing, not therapy cost, is the biggest challenge
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
Subscribe To Our Newsletter & Stay Updated